Marilyn A. Mclaughlin-murray, M.D.
Specialist
15 Hospital Drive
York, ME 03909
Who else practices at this address →
York County includes primary care (6% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Rutgers New Jersey Medical School (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 321
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: Rutgers New Jersey Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Specialist primary
NY license 214127 -
Internal Medicine Physician
ME license 20300
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mainehealth Maine Medical Center Portland, ME
- York Hospital York, ME
Medical groups
- York Hospital (198 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 321
- Services billed
- 775
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 321 | 122 |
| Established patient office or other outpatient visit, 20-29 minutes | 265 | 194 |
| Established patient office or other outpatient visit, 40-54 minutes | 94 | 54 |
| New patient office or other outpatient visit, 60-74 minutes | 42 | 42 |
| New patient office or other outpatient visit, 45-59 minutes | 24 | 24 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in York, ME | 92 |
| Anastrozole Other prescribers in York, ME | 55 |
| Prednisone Other prescribers in York, ME | 35 |
| Eliquis (apixaban) Other prescribers in York, ME | 27 |
| Imbruvica (ibrutinib) | 25 |
| Hydroxyurea Other prescribers in York, ME | 24 |
| Potassium Chloride Other prescribers in York, ME | 21 |
| Gabapentin Other prescribers in York, ME | 17 |
| Kisqali (ribociclib succinate) | 16 |
| Zolpidem Tartrate Other prescribers in York, ME | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 23 payments worth $842 in total to this clinician.
| AbbVie Inc. | $214 |
|---|---|
| Beone Medicines USA, Inc. | $124 |
| Kite Pharma, Inc. | $120 |
| AstraZeneca Pharmaceuticals LP | $92.50 |
| Astellas Pharma US Inc | $56.90 |
| Janssen Biotech, Inc. | $54.99 |
| Novartis Pharmaceuticals Corporation | $24.78 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.41 |
| Food and Beverage | $703 |
|---|---|
| Education | $139 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Aug 26, 2025 | Education IMBRUVICA · ONCOLOGY · in-kind | $83.99 |
| Janssen Biotech, Inc. Jul 11, 2025 | Education RYBREVANT · Oncology · in-kind | $54.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,548 in research payments for these studies, mostly to the institutions running them.
- A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
Eli Lilly and Company · Active, not recruiting · NCT05514054
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.